B3GNT2 and cancer: Beta-1,3-N-acetylglucosaminyltransferases (B3GNTs), a subgroup of glycosyltransferases, are linked to the onset and progression of several diseases, including autoimmune disorders, cancers, neurodevelopmental conditions, musculoskeletal disorders, and metabolic diseases (32).